Six targets (AKT1, RAF1, BRAF, EGFR, IKBKB, and STAT3) in the first 20 pathways participated in a high frequency (≥9 times), indicating that they played important roles in CRC. The gene discussed is STAT3; the disease is colorectal carcinoma.